相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune correlates for dengue vaccine development
Anon Srikiatkhachorn et al.
EXPERT REVIEW OF VACCINES (2016)
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D. Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Asymptomatic humans transmit dengue virus to mosquitoes
Veasna Duong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dengue human infection models to advance dengue vaccine development
Christian P. Larsen et al.
VACCINE (2015)
The Human CD8(+) T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
Daniela Weiskopf et al.
JOURNAL OF VIROLOGY (2015)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
Gustavo H. Dayan et al.
VACCINE (2013)
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
Adwoa D. Bentsi-Enchill et al.
VACCINE (2013)
Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
Magelda Montoya et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Underrecognized Mildly Symptomatic Viremic Dengue Virus Infections in Rural Thai Schools and Villages
In-Kyu Yoon et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naive Children, Adolescents, and Adults in Mexico City Randomized Controlled Phase 1 Trial of Safety and Immunogenicity
Jorge Poo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
Anna P. Durbin et al.
VACCINE (2011)
Experimental human challenge infections can accelerate clinical malaria vaccine development
Robert W. Sauerwein et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Antibodies Determine Virulence in Dengue
Scott B. Halstead
IMMUNOLOGY AND PATHOGENESIS OF VIRAL HEMORRHAGIC FEVERS (2009)
The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers
Anna P. Durbin et al.
HUMAN VACCINES (2006)
rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers
AP Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2
JE Blaney et al.
BMC INFECTIOUS DISEASES (2004)
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region
AP Durbin et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
分享论文
